A diabetes drug may help people quit smoking, according to researchers at the University of Texas Health Science Center at Houston (UTHealth).
Diabetes drug exenatide is being studied as a potential treatment for smoking cessation. The glucagon-like peptide-1 receptor agonist (GLP-1RA), sold by AstraZeneca under the brand name Bydureon, will be trialled in a clinical trial of 90 volunteers.
